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Background: The genetic diversity of Plasmodia species
have been extensively studied in various parts of the world.
However, limited data are available from Pakistan. This
study aimed to assess the merozoite surface protein-1
(msp-1) and 2 (msp-2) genetic diversity of Plasmodium
falciparumﬁeld isolates from Pakistan Methodology: We col-
lected a total of 240 blood samples from patients with slide
positive P. falciparum mono infections attending Aga Khan
University Hospital between Oct 2005 to Oct 2007. The diver-
sity of P. falciparuminfections were analyzed using nested
polymerase chain reactions (PCR) targeting block 2 of msp-
1 and block 3 of msp-2 with their respective allelic families
KI, RO33, MAD 20, and FC27, 3D7/IC.
Results: Length polymorphism was observed inP. falci-
parumﬁeld isolates within the allelic families of msp-1 and
msp-2. Some 75 percent of the patients carried multiple P.
falciparum genotypes and the mean numbers of msp-1 and
msp-2 genotypes per infection were 2.2 and 1.2, respec-
tively. The RO33 allelic type of msp-1 was prevalent but
as expected comparatively less polymorphic than all other
allelic families. The 3D7 and FC27 allelic types ofmsp-2were
equally distributed.
Conclusion: The P. falciparum diversity and allelic dis-
tribution found in our study was similar to previous reports
from India and Southeast Asian countries with low to mod-
erate endemicity. This is the ﬁrst report on genetic diversity
of P. falciparum ﬁeld isolates from Pakistan which may help
us understand the population structure of malaria parasite.
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Beginning with the inoculation of Plasmodium parasites
via Anopheles mosquito bites and continuing through the
blood-stage development of the parasite, a hallmark of the
host response to malaria is an inﬂammatory reaction charac-
terized by elevated histaminemia levels and tissue histamine
concentrations. Since histamine has both pro-inﬂammatory
and immunosuppressive activities, we postulated that this
vaso-active amine may participate in malaria pathogen-
esis. Employing genetic and pharmacologic approaches
we demonstrated that histamine binding to H1- and H2-
receptors increases the susceptibility of mice to Plasmodium
berghei infection. To further explore the role of histamine in
malaria pathogenesis, we used histidine decarboxylase deﬁ-
cient (HDC−/−) mice, which lack histamine. HDC−/− mice
were highly resistant to severe malaria whether mice were
infected through mosquito bites or with infected erythro-
cytes. HDC−/− mice were resistant to two lethal parasite
strains, P. berghei ANKA strain (100% of wild type mice pro-
gressed to cerebral malaria compared to 0% of HDC−/−
mice; p < 0.002), and P. berghei NK65 (0/10 HDC−/− mice
succumbed to infection vs. 10/10 wild type mice; p < 0.001).
The resistance of HDC−/− mice to cerebral malaria was
characterized by preservation of the blood brain barrier
integrity, an absence of infected erythrocyte aggregation in
the brain microvasculature, and a lack of sequestration of
pathogenic CD4+ and CD8+ T cells. This study identiﬁes a
novel inﬂammatory mechanism whereby histamine is asso-
ciated with malaria severity. Histamine-mediated signaling
discriminates between malaria-susceptible and resistant
mice. Understanding the biological effects of histamine dur-
ing infection may lead to novel strategies to manipulate the
immune response against Plasmodium parasites and to pro-
vide new therapeutic tools that minimize the development
of severe pathologies during malaria infection.
doi:10.1016/j.ijid.2008.05.842
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Background: Severe malaria still caused signiﬁcant mor-
tality in the eastern part of Indonesia. The introduction of
new antimalaria drug artemisinin derivate hopefully would
decreased mortality as shown in SEAQUAMAT study in which
overall mortality of severemalaria was 15% in the artesunate
group. Mortality and clinical manifestasion of severe malaria
might differ depend partly on age and maybe regions. The
aim of this study is to give information about clinical mani-
festasion and mortality of severe malaria at Manado Hospital
in North Sulawesi, Indonesia.
Methods: Retrospective descriptive study. Data obtain
from medical record of severe malaria patients during
2006—2007. Examination include age, sex, treatment, type
of complication, number of complications, mortality. Diag-
nosis of severe malaria based on WHO criteria. Result:
89 pts., median age 38± 26,4 year (14—78 yr). Male:
female = 63%:37%. All pts. had plasmodium falciparum. Mor-
tality 14 pts. (15,7%), with 10 of them (71%) died at age
< 40 year old. Jaundice occur in 58 pts. (65,2%), acute
renal failure in 29 pts. (32,6%), cerebral malaria in 24 pts.
(27%), severe anaemia in 8 pts. (9%), bleeding in 3 pts.
(3,4%), hyperpyrexia in 2 pts. (2,3%), algid malaria in 11
pts. (12,4%), ARDS in 6 pts. (6,8%), hypoglycemia in 3 pts.
(3,4%), relapsing seizure in 1 pts. (1,1%). One complication
found in 37 pts. (41,6%), no mortality. Two complications in
35 pts. (39,3%) with 3 pts. died (8,57%). Three complications
(mostly jaundice, ARF, cerebral) in 8 pts. (8,9%) with 3 pts.
(37,5%) died. Four or more complications (mostly jaundice,
ARF, cerebral, ARDS) in 9 pts (10,1%) with 8 pts. died (89%).
